Background: The aim of this study is to evaluate heart rate recovery (HRR) and association between coronary flow rate and HRR in patients with metabolic syndrome (MS) who had morphologically normal coronary angiogram.

Methods: Study population included 43 patients with MS and 37 control subjects without MS. All patients were selected from individuals who had recently undergone coronary angiography in our hospital and were diagnosed as having angiographically normal coronary arteries. Exercise stress test results obtained prior to coronary angiography were evaluated for calculating HRR and other parameters. In addition, coronary flow was objectively evaluated for each major coronary artery in each subject using TIMI frame count method.

Results: All HRR values calculated were detected significantly lower in MS group compared to controls (HRR first: 32 ± 9 vs. 37 ± 10; p = 0.01, second: 46 ± 11 vs. 52 ± 11; p = 0.03, third: 51 ± 12 vs. 59 ± 12; p = 0.00, fourth: 54 ± 13 vs. 61 ± 2; p = 0.02). TIMI frame counts for each major epicardial coronary artery and mean TIMI frame count were also found to be significantly higher in MS group compared to controls (left anterior descending artery:51 ± 24 vs. 39 ± 15; p = 0.009, left circumflex artery: 32 ± 11 vs. 24 ± 7; p = 0.001, right coronary artery: 33 ± 14 vs. 24 ± 10; p = 0.003, mean TIMI frame count: 38 ± 15 vs. 29 ± 9;p = 0.002). Additionally, significant negative correlations were also detected between HRR first minute and coronary TIMI frame count values in patients with MS. None of MS parameters did not affect HRR values, however mean TIMI frame count independently associated with HRR first minute (p = 0.04) in patients with MS.

Conclusions: Impaired coronary blood flow occurring in MS might be a clue of autonomic dysfunction in addition to previously known endothelial dysfunction.

Download full-text PDF

Source
http://dx.doi.org/10.5603/CJ.a2013.0119DOI Listing

Publication Analysis

Top Keywords

timi frame
24
frame count
20
coronary flow
12
coronary artery
12
coronary
11
association coronary
8
flow rate
8
heart rate
8
rate recovery
8
patients metabolic
8

Similar Publications

Background: No-reflow following primary percutaneous coronary intervention (PPCI) is challenging to treat.

Objectives: The objective of this study is to evaluate the efficacy and safety of upstream high-bolus-dose tirofiban administration in ST-segment elevation myocardial infarction (STEMI) cases undergoing PPCI on top of dual antiplatelet therapy, including ticagrelor, in comparison to selective bailout administration.

Methods: This hospital-based, randomized, single-blinded prospective interventional study was conducted on 150 patients at Assiut University Heart Hospital.

View Article and Find Full Text PDF
Article Synopsis
  • This study examined the relationship between corrected Thrombolysis in Myocardial Infarction (TIMI) frame count (CTFC) and major adverse cardiovascular events (MACE) within a month after primary percutaneous coronary intervention (PPCI).
  • The research included 80 patients at Ayatollah Rouhani Hospital, focusing on demographic data, coronary blood flow (CTFC), and the success of the intervention as indicated by ST segment resolution.
  • Results showed no significant link between CTFC and MACE rates, although more than 50% ST segment resolution correlated with fewer cardiovascular events; ultimately, CTFC was deemed unreliable for predicting MACE in this timeframe.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the relationship between endocan levels and coronary artery disease (CAD) and coronary slow flow (CSF) in a group of 169 subjects undergoing coronary angiography.
  • Both CAD and CSF patients exhibited significantly higher endocan levels compared to a control group, with similar levels between the two conditions, suggesting endocan's role in these diseases.
  • Endocan levels, particularly when exceeding 450 pg/mL, are key predictors for both CAD and CSF, highlighting its potential as an important biomarker in these cardiovascular conditions.
View Article and Find Full Text PDF

The predictors of coronary slow flow in patients undergoing coronary angiography.

Egypt Heart J

August 2024

Faculty of Medicine, Mataram University, FK UNRAM, Jl. Pendidikan, No. 37, Mataram, NTB, Indonesia.

Background: A new challenge in coronary artery disease treatment has emerged, where specific populations exhibit ischemic symptoms without any obstruction in the epicardial coronary artery. Instead, they exhibit slow coronary contrast flow, referred to as coronary slow flow (CSF). This study aims to identify several predictors of CSF.

View Article and Find Full Text PDF

Background: The diagnosis of coronary microvascular disease (CMVD) remains challenging. Perfusion PET-derived myocardial blood flow (MBF) reserve (MBFR) can quantify CMVD but is not widely available. Thrombolysis in Myocardial Infarction (TIMI) frame count (TFC) is an angiography-based method that has been proposed as a measure of CMVD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!